These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 5129617)

  • 41. Mithramycin therapy in Paget's disease.
    Russell AS; Lentle BC
    Can Med Assoc J; 1974 Feb; 110(4):397-400. PubMed ID: 4273095
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Use of gallium to treat Paget's disease of bone: a pilot study.
    Matkovic V; Apseloff G; Shepard DR; Gerber N
    Lancet; 1990 Jan; 335(8681):72-5. PubMed ID: 1967419
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Treatment of Paget's disease of bone with porcine calcitonin: clinical and metabolic responses.
    Kanis JA; Fitzpatrick K; Strong JA
    Q J Med; 1975 Jul; 44(175):399-413. PubMed ID: 1101286
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Galactosyl hydroxylysine in assessment of Paget's bone disease.
    Michalsky M; Stepan JJ; Wilczek H; Formankova J; Moro L
    Clin Chim Acta; 1995 Jan; 234(1-2):101-8. PubMed ID: 7758208
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Single infusion of zoledronate in Paget's disease of bone: a placebo-controlled, dose-ranging study.
    Buckler H; Fraser W; Hosking D; Ryan W; Maricic MJ; Singer F; Davie M; Fogelman I; Birbara CA; Moses AM; Lyles K; Selby P; Richardson P; Seaman J; Zelenakas K; Siris E
    Bone; 1999 May; 24(5 Suppl):81S-85S. PubMed ID: 10321935
    [No Abstract]   [Full Text] [Related]  

  • 46. [Treatment of 10 cases of symptomatic Paget's disease with etidronate (EHDP)].
    Jung A; Mermillod B; Schenk R; Courvoisier B; Burkhardt P; Epiney J; Fleisch
    Schweiz Med Wochenschr; 1976 Nov; 106(48):1667-73. PubMed ID: 827810
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [The value of the calcitonin test in Paget's disease of bone].
    D'Amore M; Bozzi A; Telesca ML; Carrozzo M
    Minerva Med; 1981 Apr; 72(14):865-8. PubMed ID: 7219796
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Treatment of Paget's disease with (3-amino-1-hydroxypropylidene)-1, 1-bisphosphonate (A.P.D.).
    Frijlink WB; Bijvoet OL; te Velde J; Heynen G
    Lancet; 1979 Apr; 1(8120):799-803. PubMed ID: 86042
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Treatment of Paget's disease of bone with a combination of intranasal salmon calcitonin and oral calcium and thiazide.
    Evans RA; Somers NM; Dunstan CR; Hills E; Evans M
    Calcif Tissue Int; 1991 Sep; 49(3):164-7. PubMed ID: 1933580
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Biological exploration of Paget's disease].
    Eisinger J; Laponche AM; Roux H; Recordier AM
    Rev Rhum Mal Osteoartic; 1976 Feb; 43(2):105-11. PubMed ID: 131366
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Salmon and porcine calcitonin treatment of Paget's disease of bone.
    Avramides A
    Clin Orthop Relat Res; 1977; (127):78-85. PubMed ID: 303164
    [No Abstract]   [Full Text] [Related]  

  • 52. Diphosphonates and Page's disease of bone.
    Smith R; Russell RG; Bishop M
    Lancet; 1971 May; 1(7706):945-7. PubMed ID: 4102275
    [No Abstract]   [Full Text] [Related]  

  • 53. Paget's disease of bone (osteitis deformans) treated with human synthetic calcitonin.
    Epstein S; Owen G
    S Afr Med J; 1977 Jan; 51(5):133-7. PubMed ID: 850845
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [The treatment of Paget's disease using salmon thyrocalcitonin. 8 cases (author's transl)].
    Deplante JP; Daumont A; Bouvier M; Lejeune E
    Nouv Presse Med; 1978 Nov; 7(41):3753-6. PubMed ID: 733525
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Effects of the combined calcitonin and sodium etidronate therapy in Paget's disease of bone].
    Nuti R; Turchetti V; Righi G; Vattimo A
    Minerva Med; 1982 Mar; 73(9):467-72. PubMed ID: 6801555
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Studies of variations in several biological parameters in Paget's disease (phosphatases, hydroxyproline...) before and after treatment with aspirin].
    Galmiche P; Lévy P
    Rev Rhum Mal Osteoartic; 1967 Apr; 34(4):185-92. PubMed ID: 6059924
    [No Abstract]   [Full Text] [Related]  

  • 57. [On the treatment of the osteodystrophia deformans (Paget's disease) with synthetic salmon calcitonin (author's transl)].
    Trzenschik K; Schmidt UJ; Abendroth K; Ansorg H; Graner H; Lindenhayn K; Schramm G; Kalbe I
    Z Alternsforsch; 1978; 33(5):441-51. PubMed ID: 570764
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Radiological regression in Paget's disease treated by human calcitonin.
    Woodhouse NJ; Joplin GF; MacIntyre I; Doyle FH
    Lancet; 1972 Nov; 2(7785):992-4. PubMed ID: 4116982
    [No Abstract]   [Full Text] [Related]  

  • 59. Paget's disease of the bone: observations after cessation of long-term synthetic salmon calcitonin treatment.
    Avramides A; Flores A; DeRose J; Wallach S
    J Clin Endocrinol Metab; 1976 Mar; 42(3):459-63. PubMed ID: 1254686
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Alendronate in the treatment of Paget's disease of bone.
    Khan SA; Vasikaran S; McCloskey EV; Benéton MN; Rogers S; Coulton L; Orgee J; Coombes G; Kanis JA
    Bone; 1997 Mar; 20(3):263-71. PubMed ID: 9071478
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.